Bacteria-mediated delivery of nanoparticles and cargo into cells
Source abstract
Abstract
Nanoparticles and bacteria can be used, independently, to deliver genes and proteins into mammalian cells for monitoring or altering gene expression and protein production. Here, we show the simultaneous use of nanoparticles and bacteria to deliver DNA-based model drug molecules in vivo and in vitro. In our approach, cargo (in this case, a fluorescent or a bioluminescent gene) is loaded onto the nanoparticles, which are carried on the bacteria surface. When incubated with cells, the cargo-carrying bacteria ('microbots') were internalized by the cells, and the genes released from the nanoparticles were expressed in the cells. Mice injected with microbots also successfully expressed the genes as seen by the luminescence in different organs. This new approach may be used to deliver different types of cargo into live animals and a variety of cells in culture without the need for complicated genetic manipulations.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Research and Treatments · Bacteriophages and microbial interactions · Micro and Nano Robotics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Chan, W. C. & Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016–2018 (1998).10.1126/science.281.5385.2016 ↗
2. Gao, X. et al. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotech. 16, 63–72 (2005).10.1016/j.copbio.2004.11.003 ↗
3. Lin, Z., Su, X., Mu, Y. & Jin, Q. Methods for labeling quantum dots to biomolecules. J. Nanosci. Nanotech. 4, 641–645 (2004).10.1166/jnn.2004.001 ↗
4. Voura, E. B., Jaiswal, J. K., Mattoussi, H. & Simon, S. M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nature Med. 10, 993–998 (2004).10.1038/nm1096 ↗
5. Ballou, B., Ernst, L. A. & Waggoner, A. S. Fluorescence imaging of tumors in vivo. Curr. Med. Chem. 12, 795–805 (2005).10.2174/0929867053507324 ↗
6. West, J. L. & Halas, N. J. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annu. Rev. Biomed. Eng. 5, 285–292 (2003).10.1146/annurev.bioeng.5.011303.120723 ↗
7. Seppenwoolde, J. H. et al. Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn. Reson. Med. 53, 76–84 (2005).10.1002/mrm.20320 ↗
8. Hattori, Y. & Maitani, Y. Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J. Control. Release 97, 173–183 (2004).10.1016/j.jconrel.2004.03.007 ↗
9. Jain, R. K. Haemodynamic and transport barriers to the treatment of solid tumors. Int. J. Radiat. Biol. 60, 85–100 (1991).10.1080/09553009114551621 ↗
10. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Rel. 65, 271–284 (2000).10.1016/S0168-3659(99)00248-5 ↗
11. Vassaux, G., Nitcheu, J., Jezzard, S. & Lemoine, N. R. Bacterial gene therapy strategies. J. Pathol. 208, 290–298 (2006).10.1002/path.1865 ↗
12. Vazquez-Boland, J. A. et al. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 14, 584–640 (2001).10.1128/CMR.14.3.584-640.2001 ↗
13. Finlay, B. B. & Cossart, P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 276, 718–725 (1997).10.1126/science.276.5313.718 ↗
14. Vazquez-Boland, J. A., Dominguez-Bernal, G., Gonzalez-Zorn, B., Kreft, J. & Goebel, W. Pathogenicity islands and virulence evolution in Listeria. Microbes Infect. 3, 571–584 (2001).10.1016/S1286-4579(01)01413-7 ↗
15. Hamon, M. L., Bierne, H. & Cossart, P. Listeria monocytogenes: a multifaceted model. Nature Rev. Microbiol. 4, 423–434 (2006).10.1038/nrmicro1413 ↗
16. Pilgrim, S. et al. Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Ther. 10, 2036–2045 (2003).10.1038/sj.gt.3302105 ↗
17. Dietrich, G. et al. Delivery of antigen encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nature Biotechnol. 16, 862–866 (1998).10.1038/nbt0298-181 ↗
18. Sizemore, D. R., Branstrom, A. A. & Sadoff, J. C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270, 299–302 (1995).10.1126/science.270.5234.299 ↗
19. Darji, A. et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91, 765–775 (1997).10.1016/S0092-8674(00)80465-1 ↗
20. Paglia, P., Medina, E., Arioli, I., Guzman, C. A. & Colombo, M. P. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92, 3172–3176 (1998).10.1182/blood.V92.9.3172 ↗
21. Yu, Y. A. et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nature Biotechnol. 22, 313–320 (2004).10.1038/nbt937 ↗
22. Bermudes, D., Zheng, L. M. & King, I. C. Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr. Opin. Drug Discov. Devel. 5, 194–199 (2002).
23. Loeffler, D. I., Schoen, C. U., Goebel, W. & Pilgrim, S. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes. Infect. Immun. 74, 3946–3957 (2006).10.1128/IAI.00112-06 ↗
24. Souders, N. C., Verch, T. & Paterson, Y. In vivo bactofection: Listeria can function as a DNA-cancer vaccine. DNA & Cell Biol. 25, 142–151 (2006).10.1089/dna.2006.25.142 ↗
25. Souders, N. C., Sewell, D. A., Pan, Z. K., Hussain, S. F., Rodriguez, A., Wallecha, A. & Paterson, Y. Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer. Cancer Immun. 7, 2–12 (2007).
26. Weber, W. & Fussenegger, M. Inducible gene expression in mammalian cells and mice. Methods Mol. Biol. 267, 451–466 (2004).
27. Bhunia, A. K et al. Development and characterization of a monoclonal antibody specific for Listeria monocytogenes and Listeria innocua. Infect. Immun. 59, 3176–3184 (1991).10.1128/IAI.59.9.3176-3184.1991 ↗
28. Geng, T. et al. Expression of cellular antigens of Listeria monocytogenes that react with monoclonal antibodies C11E9 and EM-7G1 under acid-, salt- or temperature-induced stress environments. J. Appl. Microbiol. 95, 762–772 (2003).10.1046/j.1365-2672.2003.02035.x ↗
29. Geng, T., Hahm, B. K. & Bhunia, A. K. Selective enrichment media affect the antibody-based detection of stress-exposed Listeria monocytogenes due to differential expression of antibody-reactive antigens identified by protein sequencing. J. Food Prot. 69, 1879–1886 (2006).10.4315/0362-028X-69.8.1879 ↗
30. Drevets, D.A. Dissemination of Listeria monocytogenes by infected phagocytes. Infect. Immun. 67, 3512–3517 (1999).10.1128/IAI.67.7.3512-3517.1999 ↗
31. Bron, P. A., Monk, I. R., Corr, S. C., Hill, C. & Gahan, C. G. Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes. Appl. Environ. Microbiol. 72, 2876–2884 (2006).10.1128/AEM.72.4.2876-2884.2006 ↗
32. Hardy, J., Margolis, J. J. & Contag, C. H. Induced biliary excretion of Listeria monocytogenes. Infect Immun. 74, 1819–1827 (2006).10.1128/IAI.74.3.1819-1827.2006 ↗
33. Miller, A. D. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. 10, 1195–2110 (2003).10.2174/0929867033457485 ↗
34. El-Aneed, A. An overview of current delivery systems in cancer gene therapy. J. Control. Rel. 94, 1–14 (2004).10.1016/j.jconrel.2003.09.013 ↗
35. Lechardeur, D. & Lukacs, G. L. Intracellular barriers to non-viral gene transfer. Curr. Gene Ther. 2, 183–194 (2002).10.2174/1566523024605609 ↗
36. Cheong, I. et al. A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science 314, 1308–1311 (2006).10.1126/science.1130651 ↗
37. Michl, P. and Gress, T. M. Bacteria and bacterial toxins as therapeutic agents for solid tumors. Curr. Cancer Drug Targets. 4, 689–702 (2004).10.2174/1568009043332727 ↗
38. Braun, L., Nato, F., Payrastre, B., Mazie, J. C. & Cossart, P. The 213-amino-acid leucine-rich repeat region of the Listeria monocytogenes InlB protein is sufficient for entry into mammalian cells, stimulation of PI 3-kinase and membrane ruffling. Mol. Microbiol. 34, 10–23 (1999).10.1046/j.1365-2958.1999.01560.x ↗
39. Tang, P., Foubister, V., Pucciarelli, G. & Finlay, B. B. Methods to study bacterial invasion. J. Microbiol. Methods 18, 227–240 (1993).10.1016/0167-7012(93)90038-J ↗
40. Zreiqat, H., Sungaran, R., Howlett, C. R. & Markovic, B. Quantitative aspects of an in situ hybridization procedure for detecting mRNAs in cells using 96-well microplates. Mol. Biotechnol. 10, 107–113 (1998).10.1007/BF02760859 ↗